Short-chain and alternative bacterial isoprenyl pyrophosphates

Short-chain and alternative bacterial isoprenyl pyrophosphates are essential metabolic intermediates, such as geranyl pyrophosphate (GPP) and farnesyl pyrophosphate (FPP), produced via the methylerythritol phosphate (MEP) pathway in many pathogenic bacteria and protozoa (Heuston et al., 2012). These molecules serve as the building blocks for critical cellular components, including the cell wall precursor undecaprenyl phosphate and electron carriers like menaquinone, which are vital for bacterial survival and virulence (Odom, 2011). A unique feature of this pathway is the production of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), a potent phosphoantigen that is recognized by human Vγ9Vδ2 T cells, triggering a rapid immune response (Morita et al., 2007). Because the MEP pathway is absent in humans, who utilize the mevalonate pathway instead, these pyrophosphates and the enzymes that produce them are highly attractive targets for the development of selective antimicrobial and antimalarial agents. Drugs like fosmidomycin target this system by inhibiting DXP reductoisomerase, leading to the depletion of these essential isoprenoid pools and subsequent cell death. Furthermore, the immunomodulatory properties of these pyrophosphates are being explored in cancer immunotherapy to harness γδ T cell activity against tumors (IUPHAR/BPS Guide to Pharmacology, 2024).

Other names

Bacterial isoprenoidsMEP pathway intermediatesPhosphoantigensNon-mevalonate pathway intermediatesDOXP pathway intermediates(E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP)

Inhibition of the 1-deoxy-D-xylulose 5-phosphate (DXP) reductoisomerase enzyme to deplete isoprenoid precursors; or acting as phosphoantigens to stimulate Vγ9Vδ2 T-cell mediated cytotoxicity.